Jorgensen is set to testify before a Senate committee on Tuesday in a hearing focused on U.S. prices for its widely popular ...

The CEO of Novo Nordisk will testify in the Senate HELP Committee tomorrow about the cost of popular diabetes and weight loss ...

It's the second lawsuit to be filed this year in Maine against insurance carriers that limit coverage of popular drugs like ...

An Australian women who's been using Ozempic to lose weight for more than a year has revealed whether it's worth the hype.

An Australian women who's been using Ozempic to lose weight for more than a year has revealed whether it's worth the hype.

Lizzo is shutting down social media rumors while continuing to share her personal fitness journey. Recently she has lost a ...

According to the Journal, the GLP-1 "pricing fight" began in late 2023, when Lilly priced Zepbound at $1,060 per month, or 20% lower than Novo Nordisk's Wegovy. Analysts told the newspaper that prices ...

Developed to treat diabetes, drugs like Ozempic now help fight obesity. Scientists newly honoured for working on them recall ...

The founders of body scanning company are hoping to list on the stock market before Christmas, backed by investors including ...

Emilia Clarke, who famously played Daenerys Targaryen, suffered two brain aneurysms. The first one was in 2011 after filming Game of Thrones, and the second in 2013. As a result she experienced ...

As the demand for GLP-1 drugs like Ozempic and Wegovy increases with consumers eager to shed pounds, the supplement industry ...

Novo Nordisk CEO Lars Fruergaard Jorgensen will testify Tuesday before a Senate panel looking into the drug maker's pricing ...